Immunopotentiators in modern vaccines /

Bibliographic Details
Other Authors:	Schijns, Virgil (Editor), O'Hagan, Derek (Editor)
Format:	eBook
Language:	English
Published:	Amsterdam : Elsevier/Academic Press, [2017]
Edition:	Second edition.
Subjects:	Immunological adjuvants. Immune response > Regulation. Vaccines. Immunotherapy. Adjuvants, Immunologic. Vaccines > immunology. Drug Delivery Systems.
Online Access:	Connect to the full text of this electronic book.

Table of Contents:

Vaccine adjuvants' mode of action: unraveling "the Immunologist's Dirty Little Secret"
The role of inflammasomes in adjuvant-driven humoral and cellular immune responses
Dendritic cells as targets of vaccines and adjuvants
Host-derived cytokines and chemokines as vaccine adjuvants
Discovery of immune potentiators as vaccine adjuvants
Current status of toll-like receptor 4 ligant vaccine adjuvants
Flagellins as adjuvants of vaccines
Toll-like receptor 7 and 8 agonists for vaccine adjuvant use
CpG Oligodeoxynucleotides as adjuvants for clinical use
Advax adjuvant: a potent and safe immunopotentiator composed of delta inulin
Natural vaccine adjuvants and immunopotentiators derived from plants, fungi, marine organisms, and insects
Polymeric particles as vaccine delivery systems
MF59: a safe and potent adjuvant for human use
The development of the adjuvant system AS01: a combination of two immunostimulants MPL and QS-21 in liposomes
Development and evaluation of AS04, a novel and improved adjuvant system containing 3-0-Desacyl-4'- monophosphoryl lipid A and aluminum salt
ISCOMATRIX adjuvant in the development of prophylactic and therapeutic vaccines
Development and evaluation of CAF01
Mineral adjuvants
Toxin-based mucosal adjuvants
Adjuvants for skin vaccination
Vaccination to treat noninfectious diseases: surveying the opportunities
A framework for evaluating nonclinical safety of novel adjuvants and adjuvanted preventive vaccines.